Condition

Stage IIIB Non-small Cell Lung Cancer

ClinicalTrials.gov condition label

Clinical trials79

Recruiting1

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.NCT06167460 · 2023-12-04

Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung CancerNCT06525246 · 2021-08-06

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)NCT04776447 · 2021-06-16

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung CancerNCT04062708 · 2021-03-10

ACTIVE_NOT_RECRUITING

Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung CancerNCT03916419 · 2019-06-20

Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung CancerNCT02655913 · 2015-12-01

Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for SurgeryNCT02262325 · 2015-06-08

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerNCT02132884 · 2015-03-01

Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family CaregiversNCT02243748 · 2015-02-05

Photodynamic Therapy During Surgery in Treating Patients With Pleural MalignancyNCT02106559 · 2014-09-04

Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung CancerNCT01958372 · 2014-08-01

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerNCT02245100 · 2014-07-22

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung CancerNCT02059889 · 2014-07-01

Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLCNCT02059967 · 2014-03-01

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer PatientsNCT01999881 · 2013-12-01

Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing ChemoradiationNCT02017925 · 2013-10-01

Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive BiomarkersNCT01935336 · 2013-09-24

Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung CancerNCT01839955 · 2013-09-01

Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung CancerNCT01781741 · 2013-03-06

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyNCT01806675 · 2013-03-04

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung CancerNCT01741636 · 2013-01-01

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor CareNCT01726296 · 2013-01-01

Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerNCT01707823 · 2012-10-01

An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)NCT01711697 · 2012-09-04

Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryNCT01411098 · 2011-10-01

Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung CancerNCT01383668 · 2011-06-01

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryNCT01345851 · 2011-03-23

ACTIVE_NOT_RECRUITING

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung CancerNCT01457469 · 2011-01-01

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerNCT01282333 · 2011-01-01

RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line ChemotherapyNCT01193868 · 2010-09-01

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsNCT01155258 · 2010-06-01

Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung CancerNCT00976677 · 2010-01-01

Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung CancerNCT00986674 · 2009-09-01

Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerNCT00778167 · 2008-10-01

Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By SurgeryNCT00662311 · 2008-03-01

AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination ChemotherapyNCT00638937 · 2008-02-01

Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerNCT00499655 · 2007-11-01

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerNCT00564733 · 2007-10-01

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT01557959 · 2007-07-01

Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung CancerNCT00481078 · 2007-05-01

Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00459342 · 2007-03-01

E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00400829 · 2006-11-01

Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabNCT00387374 · 2006-10-01

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung CancerNCT00368992 · 2006-08-01

Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerNCT00369551 · 2006-06-01

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00408460 · 2006-02-01

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung CancerNCT00247416 · 2005-08-01

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerNCT00118183 · 2005-07-01

Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00138203 · 2005-06-01

Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung CancerNCT00118144 · 2005-06-01

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerNCT00101348 · 2005-01-01

Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00098540 · 2004-12-01

Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00085280 · 2004-09-01

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung CancerNCT00087412 · 2004-09-01

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung CancerNCT00093756 · 2004-09-01

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerNCT00087191 · 2004-05-01

CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung CancerNCT00079235 · 2004-02-01

Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung CancerNCT00062101 · 2004-01-01

Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung CancerNCT00075751 · 2004-01-01

Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00088959 · 2003-12-01

Common interventions

Leading sponsors

National Cancer Institute (NCI)44 University of Washington4 City of Hope Medical Center3 Ohio State University Comprehensive Cancer Center3 Fox Chase Cancer Center2 Virginia Commonwealth University2 Wake Forest University Health Sciences2 Alliance Foundation Trials, LLC.1 Barbara Ann Karmanos Cancer Institute1 Clifford Hospital, Guangzhou, China1 Emory University1 Fundación GECP1 Gene Solutions1 Jonsson Comprehensive Cancer Center1 Mayo Clinic1

Trial status mix

COMPLETED59

TERMINATED11

WITHDRAWN5

ACTIVE_NOT_RECRUITING2

RECRUITING1

UNKNOWN1

Phase mix

PHASE243

PHASE125

NA12

PHASE34

EARLY_PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.